The NRAS mutation is found in several cancers such as melanoma (13 ~ 25%), colorectal cancer (1 ~ 6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is known that the response to colorectal cancer drug such as Erbitux and Cetuximab decreased and the prognosis of the patient with metastatic colorectal cancer is poor if the patient has NRAS mutation.
PNAClamp™ Mutation Detection Kit NRAS
For detection of NRAS mutations in tissue biopsies
Cat. No. PNAC-1101
Other products
PCR Workstation (NB603WS)
The biological safety cabinet with HEPA filter and UV PCR...
PathoSEEK® Multiplex Detection
The PathoSEEK® microbial safety testing platform is the only method...
Microcentrifuge tubes with SureSeal ™ screw caps
SureSeal™ sterile screw-capped microtubes come in a variety of sizes,...
Strip tubes – CP0111
200 uL tubes for qPCR in white strip with transparent...